Nationwide Trends in the Current Management of Desmoid (Aggressive) Fibromatosis von Eastley, N.C, Hennig, I.M, Esler, C.P, Ashford, R.U

Volltext

99. Nationwide trends in the current management of desmoid (aggressive) fibromatosis von Eastley, N, Hennig, I.M, Esler, C.P, Ashford, R.U

Volltext

74: TRANSCRiPT: a study to assess Tarceva® in NSCLC with epidermal growth factor receptor mutations von Lewanski, C, Hennig, I.M, Muthukumar, D.M, Benepal, T, Tahir, S, Garcia, A, Summerhayes, M, De Queiros, S.K

Volltext

Long term follow-up of the MRC TE23 randomized phase II trial of intensive induction chemotherapy (CBOP/BEP) in poor prognosis germ cell tumours (GCT) (CRUK/05/014; ISRCTN53643604) von Huddart, R.A., Cafferty, F., White, J., Shamash, J., Hennig, I.M., Cullen, M., Stenning, S.

Volltext

Adenovirus-mediated hypoxia-targeted gene therapy using HSV thymidine kinase and bacterial nitroreductase prodrug-activating genes in vitro and in vivo von Harvey, T J, Hennig, I M, Shnyder, S D, Cooper, P A, Ingram, N, Hall, G D, Selby, P J, Chester, J D

Volltext

Collective escape processes in many-particle systems von Fugmann, S., Hennig, D., Schimansky-Geier, L., Sokolov, I.M.

Volltext